Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Increased relative abundance of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae within the gut microbiota is associated with risk of bloodstream infection in long-term acute care hospital patients.

Shimasaki T, Seekatz A, Bassis C, Rhee Y, Yelin RD, Fogg L, Dangana T, Cisneros EC, Weinstein RA, Okamoto K, Lolans K, Schoeny M, Lin MY, Moore NM, Young VB, Hayden MK; Centers for Disease Control and Prevention Epicenters Program.

Clin Infect Dis. 2018 Sep 18. doi: 10.1093/cid/ciy796. [Epub ahead of print]

PMID:
30239622
2.

Gut Microbiota and Clinical Features Distinguish Colonization With Klebsiella pneumoniae Carbapenemase-Producing Klebsiella pneumoniae at the Time of Admission to a Long-term Acute Care Hospital.

Seekatz AM, Bassis CM, Fogg L, Moore NM, Rhee Y, Lolans K, Weinstein RA, Lin MY, Young VB, Hayden MK; Centers for Disease Control and Prevention Epicenters Program.

Open Forum Infect Dis. 2018 Jul 31;5(8):ofy190. doi: 10.1093/ofid/ofy190. eCollection 2018 Aug.

3.

Presence of multiple Clostridium difficile strains at primary infection is associated with development of recurrent disease.

Seekatz AM, Wolfrum E, DeWald CM, Putler RKB, Vendrov KC, Rao K, Young VB.

Anaerobe. 2018 Oct;53:74-81. doi: 10.1016/j.anaerobe.2018.05.017. Epub 2018 May 31.

PMID:
29859301
4.

Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection.

Seekatz AM, Theriot CM, Rao K, Chang YM, Freeman AE, Kao JY, Young VB.

Anaerobe. 2018 Oct;53:64-73. doi: 10.1016/j.anaerobe.2018.04.001. Epub 2018 Apr 12.

PMID:
29654837
5.

Clostridium difficile Infection and the Tangled Web of Interactions Among Host, Pathogen, and Microbiota.

Seekatz AM, Young VB.

Gastroenterology. 2018 May;154(6):1573-1576. doi: 10.1053/j.gastro.2018.03.036. Epub 2018 Mar 28. No abstract available.

PMID:
29601830
6.

High-resolution profiling of the gut microbiome reveals the extent of Clostridium difficile burden.

Daquigan N, Seekatz AM, Greathouse KL, Young VB, White JR.

NPJ Biofilms Microbiomes. 2017 Dec 5;3:35. doi: 10.1038/s41522-017-0043-0. eCollection 2017.

7.

Comparison of stool versus rectal swab samples and storage conditions on bacterial community profiles.

Bassis CM, Moore NM, Lolans K, Seekatz AM, Weinstein RA, Young VB, Hayden MK; CDC Prevention Epicenters Program.

BMC Microbiol. 2017 Mar 31;17(1):78. doi: 10.1186/s12866-017-0983-9.

8.

A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility.

Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A, Young VB, Henrissat B, Wilmes P, Stappenbeck TS, Núñez G, Martens EC.

Cell. 2016 Nov 17;167(5):1339-1353.e21. doi: 10.1016/j.cell.2016.10.043.

9.

Infection: Modulation of Clostridium difficile infection by dietary zinc.

Seekatz AM, Young VB.

Nat Rev Gastroenterol Hepatol. 2016 Dec;13(12):686-688. doi: 10.1038/nrgastro.2016.177. Epub 2016 Nov 9. No abstract available.

PMID:
27826138
10.

Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.

Nagao-Kitamoto H, Shreiner AB, Gillilland MG 3rd, Kitamoto S, Ishii C, Hirayama A, Kuffa P, El-Zaatari M, Grasberger H, Seekatz AM, Higgins PD, Young VB, Fukuda S, Kao JY, Kamada N.

Cell Mol Gastroenterol Hepatol. 2016 Mar 3;2(4):468-481. eCollection 2016 Jul.

11.

Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection.

Seekatz AM, Rao K, Santhosh K, Young VB.

Genome Med. 2016 Apr 27;8(1):47. doi: 10.1186/s13073-016-0298-8.

12.

Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease.

Seekatz AM, Theriot CM, Molloy CT, Wozniak KL, Bergin IL, Young VB.

Infect Immun. 2015 Oct;83(10):3838-46. doi: 10.1128/IAI.00459-15. Epub 2015 Jul 13.

13.

Effects of tigecycline and vancomycin administration on established Clostridium difficile infection.

Theriot CM, Schumacher CA, Bassis CM, Seekatz AM, Young VB.

Antimicrob Agents Chemother. 2015 Mar;59(3):1596-604. doi: 10.1128/AAC.04296-14. Epub 2014 Dec 29.

14.

Clostridium difficile and the microbiota.

Seekatz AM, Young VB.

J Clin Invest. 2014 Oct;124(10):4182-9. doi: 10.1172/JCI72336. Epub 2014 Jul 18. Review.

15.

Recovery of the gut microbiome following fecal microbiota transplantation.

Seekatz AM, Aas J, Gessert CE, Rubin TA, Saman DM, Bakken JS, Young VB.

MBio. 2014 Jun 17;5(3):e00893-14. doi: 10.1128/mBio.00893-14.

16.

Differential response of the cynomolgus macaque gut microbiota to Shigella infection.

Seekatz AM, Panda A, Rasko DA, Toapanta FR, Eloe-Fadrosh EA, Khan AQ, Liu Z, Shipley ST, Detolla LJ, Sztein MB, Fraser CM.

PLoS One. 2013 Jun 5;8(6):e64212. doi: 10.1371/journal.pone.0064212. Print 2013.

17.

Impact of oral typhoid vaccination on the human gut microbiota and correlations with s. Typhi-specific immunological responses.

Eloe-Fadrosh EA, McArthur MA, Seekatz AM, Drabek EF, Rasko DA, Sztein MB, Fraser CM.

PLoS One. 2013 Apr 24;8(4):e62026. doi: 10.1371/journal.pone.0062026. Print 2013.

18.

Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling.

Cole LE, Laird MH, Seekatz A, Santiago A, Jiang Z, Barry E, Shirey KA, Fitzgerald KA, Vogel SN.

J Leukoc Biol. 2010 Feb;87(2):275-81. doi: 10.1189/jlb.0909619. Epub 2009 Nov 4.

Supplemental Content

Loading ...
Support Center